Long-Term Diabetes Care Plan

Type 2 diabetes is a condition managed across decades, not resolved in a single intervention. A long-term diabetes care plan gives that management a structure: daily habits that maintain glucose stability, quarterly check-ins that catch drift before it becomes a problem, annual screenings that detect complications in their earliest and most treatable stages, and a clear framework for when to escalate care. Without this structure, the years between appointments become a gap where complications develop quietly and treatment plans drift out of alignment with current evidence. This guide builds the framework — based on the ADA Standards of Care 2024 and the clinical evidence behind it.

The Foundation — A1c and Blood Sugar Targets

What A1c Target Should You Be Working Toward?

The A1c is the central metric of long-term diabetes management. It measures average blood glucose over the past two to three months and is the standard by which treatment efficacy is judged over time. The ADA Standards of Care 2024 recommend an A1c below 7% for most non-pregnant adults with Type 2 diabetes — a target associated with significant reduction in microvascular complication risk. This target is individualized: younger, healthier adults may be appropriate for a more stringent target of below 6.5%, while older adults with significant comorbidities may be managed at 7.5–8%.

The testing schedule for A1c reflects how well the current plan is working: the ADA recommends at least twice yearly for adults who are at or near their target, and quarterly for those not at goal or who have recently changed medications. If A1c rises above target on two consecutive quarterly tests, the treatment plan should be reviewed — not simply monitored further. Ask your provider what would trigger a medication change or referral, so you have a clear expectation.

Daily Blood Sugar Targets

For adults who monitor blood glucose at home, the ADA targets for Type 2 diabetes are: fasting glucose of 80–130 mg/dL and post-meal glucose below 180 mg/dL (two hours after the start of a meal). These are guidance ranges, not pass/fail thresholds. A single reading outside the range is not a crisis — the pattern over days and weeks is what matters.

How often you need to check depends on your medication regimen. Adults on insulin need more frequent monitoring to drive dose adjustments and manage hypoglycemia risk. Adults on metformin alone or managing primarily through lifestyle change typically do not need to check multiple times per day. If you are not sure how often to monitor given your current medications, ask your provider — and ask whether continuous glucose monitoring (CGM) is appropriate for your situation.

Quarterly Care Tasks

What Should Happen Every 3–6 Months?

At each quarterly visit, the following should be addressed:

A1c test. The numerical result tells you and your provider whether the current treatment plan is working. A1c that has moved toward target since the last visit supports continuing the current plan. A1c that has risen above target — or plateaued above target for two or more quarters — should trigger a treatment discussion.

Blood pressure measurement. The ADA recommends a blood pressure target below 130/80 mmHg for most adults with Type 2 diabetes. Blood pressure is measured at every routine diabetes visit. If it’s consistently above target, treatment adjustments are typically indicated.

Weight and BMI. Weight changes of more than a few pounds over a quarter are clinically significant in diabetes management. Deliberate, sustained weight loss may allow medication reduction. Unexpected weight loss can indicate poor glycemic control or other health issues.

Medication review. Is the current regimen still the right one? Type 2 diabetes is progressive — the treatment plan that was optimal at diagnosis may not remain optimal over years. Ask at each visit: “Is there anything about my current medication plan you would consider changing?”

Brief foot inspection. At each visit, shoes and socks should come off for a brief inspection — a quick look for wounds, ulcers, skin changes, or calluses that may have developed since the last visit. Adults with peripheral neuropathy may not notice an injury without this check.

How to Prepare for Quarterly Visits

The most productive quarterly visits are ones where you arrive with data. Bring your glucose log or a CGM report for the past two weeks. Bring an updated medication list with current doses and timing. Note any new symptoms — fatigue, foot tingling, changes in urination, vision changes — in writing rather than trusting memory in the moment. Bring your questions in writing. Providers who see written questions at the start of an appointment consistently address more of them.

Annual Screening Schedule

Eyes — Dilated Retinal Exam

Diabetic retinopathy is damage to the blood vessels that supply the retina, caused by sustained elevated blood glucose. It affects approximately one in three adults with diabetes and is a leading cause of preventable vision loss and blindness in working-age adults. In its early stages, retinopathy produces no symptoms — vision loss occurs later, when the disease is more advanced. The only way to detect it early is through a dilated retinal exam.

For adults with Type 2 diabetes, the ADA recommends a dilated eye exam at the time of diagnosis and annually thereafter, or every two to three years for adults with consistently normal results and well-controlled A1c. If early retinopathy is detected, exam frequency may increase to every six to twelve months. Treatment options for early retinopathy include laser therapy and anti-VEGF injections — both most effective when disease is caught early.

Kidneys — Urine Albumin and eGFR

Diabetic nephropathy — kidney disease caused by diabetes — is the leading cause of end-stage kidney disease in the United States, and approximately one in four adults with diabetes has some degree of kidney involvement. Annual screening captures it early, when it is most manageable.

Kidney screening involves two tests: the urine albumin-to-creatinine ratio (UACR), which detects small amounts of protein in the urine (an early sign of kidney damage), and the estimated glomerular filtration rate (eGFR), which measures how efficiently the kidneys are filtering blood. Early diabetic kidney disease is manageable with medications — ACE inhibitors, ARBs, and SGLT-2 inhibitors have demonstrated kidney-protective effects. When eGFR falls below 60, nephrology co-management should be considered. When eGFR falls below 30, nephrology referral is standard.

Feet — Comprehensive Foot Exam

Peripheral neuropathy — nerve damage in the feet and lower legs — affects approximately 50% of adults with long-standing Type 2 diabetes. The protective sensation that would normally alert a person to an injury or ulcer is diminished or absent, meaning wounds can develop and worsen without the patient’s awareness. Combined with peripheral artery disease (PAD), which reduces blood flow to the legs and feet, diabetic foot complications can progress rapidly.

The annual comprehensive foot exam assesses loss of protective sensation (using a 10-gram monofilament), peripheral pulses, skin integrity, and nail condition. High-risk feet — those with neuropathy, PAD, prior ulcers, or prior amputation — require more frequent examination and may warrant podiatry referral. Between annual exams, a daily foot self-check is the most effective early detection tool.

Cardiovascular — Lipids, Blood Pressure, and Cardiac Risk

Cardiovascular disease is the leading cause of death in adults with Type 2 diabetes. The ADA Standards of Care 2024 recommend: LDL below 70 mg/dL for adults with established cardiovascular disease; LDL below 100 mg/dL for those without established CVD; a moderate- to high-intensity statin for most adults with Type 2 diabetes aged 40–75. Blood pressure below 130/80 mmHg, typically managed with an ACE inhibitor or ARB, which also provide kidney protection. For adults with Type 2 diabetes and established cardiovascular disease, GLP-1 receptor agonists and SGLT-2 inhibitors are preferred agents for their demonstrated reduction in cardiovascular events and mortality — independent of A1c level.

Medication Management Over Time

How Diabetes Medications Change Over Time

Type 2 diabetes is a progressive condition. The beta cells in the pancreas that produce insulin decline in function over time, and the treatment plan that was optimal at diagnosis will, for most adults, need to evolve over years. This is not a sign of failure — it is the expected trajectory of the disease. Metformin remains a cornerstone of treatment throughout the course, but most adults eventually need additional agents. The decision about which to add is increasingly guided by comorbidities: GLP-1 receptor agonists for adults with established cardiovascular disease or obesity, SGLT-2 inhibitors for those with cardiovascular disease or chronic kidney disease, and insulin when other medications are insufficient.

Insulin initiation is often experienced by patients as a milestone they wanted to avoid. The clinical reality is more nuanced: starting insulin when it is clinically indicated, rather than delaying out of reluctance, produces better glucose control with less complication risk. Long-acting once-daily basal insulins are significantly more manageable than older insulin regimens, with minimal hypoglycemia risk in most patients.

Reviewing Your Medication Plan Annually

At least once a year, ask your provider for a full medication review: Are there newer options that might be more effective or better tolerated? Does my current regimen address my specific comorbidities (cardiovascular disease, kidney disease, obesity)? Are any medications causing side effects I’ve been tolerating unnecessarily? Has any evidence changed in the past year that should affect my treatment?

Lifestyle Habits as Long-Term Medicine

Physical Activity as a Core Treatment

Physical activity reduces A1c, improves insulin sensitivity, supports weight management, reduces cardiovascular risk, and improves mood and sleep quality. The ADA Standards of Care 2024 recommend at least 150 minutes of moderate-intensity aerobic activity per week distributed across at least three days, and resistance training at least two days per week. Reducing sedentary time — breaking up long periods of sitting with brief activity — is also associated with improved glucose levels.

The long-term challenge is maintaining consistency across years, through illness, schedule changes, and motivation fluctuations. Building physical activity into daily routine — walking to work, taking stairs, scheduling specific activity times — is more sustainable than treating it as a separate effort. When temporary setbacks reduce activity for days or weeks, returning to the target as soon as possible rather than abandoning the goal is the priority.

Dietary Approach for the Long Term

Long-term dietary management for Type 2 diabetes is not a temporary intervention — it is a sustained pattern of eating. The evidence-supported dietary principles: reduce refined carbohydrates (white bread, white rice, sugary beverages, pastries, ultra-processed snacks), increase fiber intake (vegetables, legumes, whole grains, nuts), choose lean protein sources, and limit alcohol. No single dietary pattern is mandated — Mediterranean, low-carbohydrate, plant-based, and DASH approaches all have supporting evidence. The one that can be maintained consistently is the right one.

Sleep quality and stress management are often overlooked in diabetes management but affect glucose levels in measurable ways. Poor sleep elevates cortisol and impairs insulin sensitivity. Chronic stress produces similar hormonal effects. Treating obstructive sleep apnea, if present, is part of the long-term care plan.

Preventive Care and Vaccines

Adults with Type 2 diabetes are at higher risk of complications from several vaccine-preventable illnesses. An annual influenza vaccine is recommended for all adults with diabetes. The pneumococcal vaccine series should be completed per current ACIP guidance. COVID-19 vaccines and boosters should be kept current. Dental care twice yearly is part of long-term diabetes care — periodontal disease is bidirectionally associated with poor glycemic control, and treating it can modestly improve A1c in some studies. Mental health screening is recommended annually by ADA — depression affects approximately 15–25% of adults with diabetes and significantly impairs self-management. If you are struggling with the emotional burden of diabetes management, raise it at your next visit.

When to Escalate — Recognizing Changes That Need Attention

Contact your provider or seek same-day care if you notice: a foot wound or infection that is not healing within a few days; sudden vision changes; symptoms of hypoglycemia becoming more frequent or severe; chest pain or shortness of breath; or any new symptom significantly affecting daily function.

Within the scheduled care framework, escalation to specialist care is appropriate when: A1c remains above target despite two or more medication classes; eGFR declines to below 60 (consider nephrology co-management) or below 30 (nephrology referral); retinopathy is found on the annual eye exam (ophthalmology for treatment planning); the foot exam reveals significant neuropathy, PAD, or a current wound (podiatry referral); or if pregnancy is being considered.

Our doctor visit checklist for diabetes provides detailed appointment preparation for each care visit. Our questions to ask about Type 2 diabetes covers the specific clinical questions to raise at diagnosis and follow-up. Our living well with diabetes guide covers the day-to-day self-management approach that sustains this plan. Our questions to ask about prediabetes provides the foundation for adults who caught the condition at the prediabetes stage.

The ADA Standards of Care 2024 is the clinical authority behind every target and schedule in this guide. The CDC’s diabetes statistics report provides the prevalence and complication burden data. The NIDDK’s Type 2 diabetes overview covers the clinical fundamentals of the condition.

Frequently Asked Questions

What is included in a long-term diabetes care plan?

A long-term diabetes care plan includes: a personalized A1c target and testing schedule (at least twice yearly at goal, quarterly if not); daily blood sugar monitoring appropriate to your medication regimen; quarterly review of A1c, blood pressure, weight, medications, and a brief foot inspection; an annual schedule of complication screening (dilated eye exam, kidney function tests, comprehensive foot exam, lipid panel, blood pressure); an active lifestyle plan (150 min/week aerobic activity, resistance training twice weekly); a sustainable dietary approach; preventive care (annual flu vaccine, pneumococcal vaccine series, dental care twice yearly); and a clear framework for when to escalate care.

How often should someone with Type 2 diabetes see a doctor?

The ADA recommends A1c testing at least twice yearly for adults at goal, and quarterly for those not at goal or after medication changes. In practice, this typically means provider visits two to four times per year. Annual visits address the full screening schedule: eye exam, kidney function, comprehensive foot exam, lipid panel, and blood pressure. Additional visits may be needed for medication changes, new symptoms, or emerging complications.

What annual tests should people with diabetes have?

The ADA Standards of Care 2024 recommend the following annual assessments: dilated eye exam (retinopathy screening), urine albumin-to-creatinine ratio and eGFR (kidney function), comprehensive foot exam (neuropathy and PAD screening), lipid panel (LDL, HDL, triglycerides), blood pressure measurement, A1c (if not done more frequently), and annual mental health screening for depression and diabetes distress. Vaccine status (influenza, pneumococcal, COVID-19) should be reviewed annually. Weight and BMI should be recorded at every visit.

Can Type 2 diabetes be managed long-term without insulin?

Many adults with Type 2 diabetes are managed effectively with oral and non-insulin injectable medications throughout their lives. Metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, and other agents are sufficient for glycemic control in many patients. However, Type 2 diabetes is progressive, and some adults will require insulin over time as beta cell function declines. For others, intensive lifestyle intervention — particularly significant weight loss — can improve glucose control to the point where medications are reduced. The trajectory varies based on duration of diabetes, current A1c, and lifestyle factors.

What lifestyle habits are most important for long-term diabetes management?

The most evidence-supported long-term lifestyle habits are: consistent physical activity (at least 150 minutes per week of moderate-intensity aerobic exercise plus resistance training twice weekly), a sustainable dietary pattern that reduces refined carbohydrates and ultra-processed foods and increases fiber, adequate sleep (seven or more hours), and stress management. Weight management — particularly maintaining weight loss achieved through lifestyle change or medication — is the most impactful single modifiable factor for long-term A1c control. Consistency over years matters far more than short-term intensity.

A long-term diabetes care plan is not a promise that complications won’t occur — it is a structure that makes early detection and treatment more likely, and sustained management less overwhelming. The daily habits, quarterly check-ins, and annual screenings described here are the standard the ADA recommends and the evidence supports. Following this framework consistently, year after year, is the best available approach to living well with Type 2 diabetes.

Building the Long Game — Managing Diabetes Across Decades

Long-term diabetes management is less like a treatment course and more like a set of habits maintained across the full arc of adulthood. The challenge is not knowing what to do — the evidence base is clear, and this guide summarizes it — but sustaining the structure over years when motivation fluctuates, life circumstances change, and the routine of diabetes care can begin to feel like a burden rather than a health investment. Understanding why the long game matters is part of what makes it sustainable.

The compounding benefit of consistent control. A1c reduction that is sustained for years produces proportionally greater reduction in complication risk than A1c reduction that is inconsistent. The UKPDS (UK Prospective Diabetes Study), the landmark long-term study of Type 2 diabetes management, demonstrated that for every 1% reduction in A1c sustained over years, the risk of microvascular complications dropped by approximately 35–37%. This is the clinical evidence behind why consistent management — not perfect management — changes outcomes. An A1c that is 7.2% this quarter and 7.1% next quarter, trending gradually toward the goal, is producing benefit even before it crosses the target threshold.

Preparing for the years when diabetes management becomes more complex. Most adults with Type 2 diabetes will, over the course of years, develop at least one additional chronic condition — hypertension, dyslipidemia, chronic kidney disease, or cardiovascular disease — that intersects with their diabetes management. Planning for this complexity, rather than being surprised by it, changes the experience. Adults who have an established relationship with their primary care provider and a care team in place are better positioned to add specialist co-management seamlessly when conditions evolve. Building that team early — even before you need every member of it — is part of the long game.

Maintaining access to care over time. Insurance coverage changes. Providers retire or move. Pharmacies close. Life changes — moves, family responsibilities, job changes — disrupt care routines. Each of these disruptions is an opportunity for the care plan to drift, and for the compounding of missed screenings, delayed medication adjustments, and gradual A1c rise to produce, years later, the complications that consistent management was designed to prevent. Building redundancy into your care plan — knowing more than one provider who manages your diabetes, keeping an updated medication list accessible, understanding your insurance coverage for each element of the screening schedule — reduces the impact of these inevitable disruptions.

Diabetes technology and the evolving treatment landscape. The technology available for diabetes management has changed significantly over the past decade and will continue to evolve. Continuous glucose monitors now provide real-time data accessible on a smartphone and share data with providers between appointments. Automated insulin delivery systems — combining CGM with insulin pumps — are increasingly available and effective. New medications continue to expand the options for adults whose current regimen has plateaued. Part of the long-term diabetes care plan is staying engaged with the evolving landscape: asking your provider at annual visits what is new, what might be relevant to your situation, and whether any recent evidence should change your approach.

Sources: American Diabetes Association Standards of Care 2024; Centers for Disease Control and Prevention (2023); National Institute of Diabetes and Digestive and Kidney Diseases (2023); Mayo Clinic (2024).